{"id":23536,"date":"2023-03-29T08:15:39","date_gmt":"2023-03-29T08:15:39","guid":{"rendered":"https:\/\/triniti.eu\/experience\/triniti-jurex-represented-lithuanian-biotech-start-up-droplet-genomics-in-raising-a-eur-4-5-million-venture-capital-investment\/"},"modified":"2023-03-29T09:23:35","modified_gmt":"2023-03-29T09:23:35","slug":"triniti-jurex-represented-lithuanian-biotech-start-up-droplet-genomics-in-raising-a-eur-4-5-million-venture-capital-investment","status":"publish","type":"experience","link":"https:\/\/triniti.eu\/lt\/patirtis\/triniti-jurex-represented-lithuanian-biotech-start-up-droplet-genomics-in-raising-a-eur-4-5-million-venture-capital-investment\/","title":{"rendered":"Triniti Jurex atstovavo lietuvi\u0173 biotechnologij\u0173 startuol\u012f \u201eDroplet Genomics\u201c pritraukiant 4,5 mln. Eur rizikos kapitalo investicij\u0105"},"content":{"rendered":"<p>Lietuvi\u0173 biotechnologij\u0173 startuolis \u201eDroplet Genomics\u201c pritrauk\u0117 4,5 mln. Eur rizikos kapitalo investicij\u0105 bei paskelb\u0117, kad toliau bus \u017einomas nauju pavadinimu \u2013 \u201eAtrandi Biosciences\u201c.<\/p>\n<p>Pagrindiniai \u201elate seed\u201c stadijos raundo investuotojai buvo \u201eVsquared Ventures\u201c, pirmoji \u012fmon\u0117s investuotoja \u201ePractica Capital\u201c ir \u201eMeta Planet\u201c. Pritraukusi investicij\u0105 \u012fmon\u0117 ketina spartinti pl\u0117tr\u0105 \u012fsteigdama komand\u0105 JAV bei t\u0119sdama la\u0161eli\u0173 mikroskys\u010di\u0173 ir pavieni\u0173 l\u0105steli\u0173 tyrim\u0173 technologij\u0173 komercializavim\u0105.<\/p>\n<p>TRINITI JUREX teik\u0117 i\u0161samias konsultacijas startuoliui d\u0117l pasirengimo investicijai ir jos strukt\u016brizavimo pagal sutartas s\u0105lyg\u0173 apra\u0161o s\u0105lygas su naujais A serijos investuotojais, \u012fskaitant esam\u0173 konvertuojam\u0173j\u0173 obligacij\u0173 ir paskol\u0173 konvertavim\u0105 \u012f nuosav\u0105 kapital\u0105, derybas d\u0117l tarpin\u0117s konvertuojamosios paskolos sutarties ir jos sudarymo, akcij\u0173 i\u0161leidim\u0105 pagal galiojan\u010dias pasirinkimo sutartis, vidinio akcij\u0173 perskirstymo tarp steig\u0117j\u0173 ir investuotoj\u0173 \u012fgyvendinim\u0105 ir konsultacijas d\u0117l deryb\u0173 su A serijos investuotojais d\u0117l investicij\u0173 \u012f nuosav\u0105 kapital\u0105. Sandoris buvo sud\u0117tingas, tod\u0117l reik\u0117jo koordinuoti daugelio \u0161ali\u0173 veikl\u0105 skirtingose jurisdikcijose, rengti kiekvieno \u012fstatinio kapitalo didinimo etapo, vidinio akcij\u0173 perskirstymo, A serijos investicij\u0173 ir akcinink\u0173 susitarim\u0173 dokumentus, taip pat der\u0117tis su daugeliu \u0161ali\u0173, turin\u010di\u0173 skirting\u0105 patirt\u012f ir skirtingo lygio investicinius interesus, t. y. nuo dideli\u0173 investuotoj\u0173, toki\u0173 kaip &#8220;Vsquared&#8221;, &#8220;Metaplanet&#8221; ir &#8220;Practica&#8221;, iki verslo angel\u0173 investuotoj\u0173. Procesas truko apie \u0161e\u0161is m\u0117nesius.<\/p>\n","protected":false},"featured_media":0,"template":"","experience_practice_area":[289],"person_countries":[644,248],"people_industries":[],"class_list":["post-23536","experience","type-experience","status-publish","hentry","experience_practice_area-privatus-kapitalas-rizikos-kapitalas-ir-startuoliai","person_countries-all-lt","person_countries-lietuva"],"acf":{"experience_photo":23524,"og_photo":23532,"experience_related_people":[9077,3858,3862],"translated":"Translated"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Triniti Jurex atstovavo lietuvi\u0173 biotechnologij\u0173 startuol\u012f \u201eDroplet Genomics\u201c pritraukiant 4,5 mln. Eur rizikos kapitalo investicij\u0105 | TRINITI JUREX - Baltijos \u0161ali\u0173 advokat\u0173 kontora<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/triniti.eu\/lt\/patirtis\/triniti-jurex-represented-lithuanian-biotech-start-up-droplet-genomics-in-raising-a-eur-4-5-million-venture-capital-investment\/\" \/>\n<meta property=\"og:locale\" content=\"lt_LT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Triniti Jurex atstovavo lietuvi\u0173 biotechnologij\u0173 startuol\u012f \u201eDroplet Genomics\u201c pritraukiant 4,5 mln. Eur rizikos kapitalo investicij\u0105 | TRINITI JUREX - Baltijos \u0161ali\u0173 advokat\u0173 kontora\" \/>\n<meta property=\"og:description\" content=\"Lietuvi\u0173 biotechnologij\u0173 startuolis \u201eDroplet Genomics\u201c pritrauk\u0117 4,5 mln. Eur rizikos kapitalo investicij\u0105 bei paskelb\u0117, kad toliau bus \u017einomas nauju pavadinimu \u2013 \u201eAtrandi Biosciences\u201c. Pagrindiniai \u201elate seed\u201c stadijos raundo investuotojai buvo \u201eVsquared Ventures\u201c, pirmoji \u012fmon\u0117s investuotoja \u201ePractica Capital\u201c ir \u201eMeta Planet\u201c. Pritraukusi investicij\u0105 \u012fmon\u0117 ketina spartinti pl\u0117tr\u0105 \u012fsteigdama komand\u0105 JAV bei t\u0119sdama la\u0161eli\u0173 mikroskys\u010di\u0173 ir pavieni\u0173 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/triniti.eu\/lt\/patirtis\/triniti-jurex-represented-lithuanian-biotech-start-up-droplet-genomics-in-raising-a-eur-4-5-million-venture-capital-investment\/\" \/>\n<meta property=\"og:site_name\" content=\"TRINITI JUREX - Baltijos \u0161ali\u0173 advokat\u0173 kontora\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-29T09:23:35+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\u0117\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/triniti.eu\/lt\/patirtis\/triniti-jurex-represented-lithuanian-biotech-start-up-droplet-genomics-in-raising-a-eur-4-5-million-venture-capital-investment\/\",\"url\":\"https:\/\/triniti.eu\/lt\/patirtis\/triniti-jurex-represented-lithuanian-biotech-start-up-droplet-genomics-in-raising-a-eur-4-5-million-venture-capital-investment\/\",\"name\":\"Triniti Jurex atstovavo lietuvi\u0173 biotechnologij\u0173 startuol\u012f \u201eDroplet Genomics\u201c pritraukiant 4,5 mln. Eur rizikos kapitalo investicij\u0105 | TRINITI JUREX - Baltijos \u0161ali\u0173 advokat\u0173 kontora\",\"isPartOf\":{\"@id\":\"https:\/\/triniti.eu\/#website\"},\"datePublished\":\"2023-03-29T08:15:39+00:00\",\"dateModified\":\"2023-03-29T09:23:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/triniti.eu\/lt\/patirtis\/triniti-jurex-represented-lithuanian-biotech-start-up-droplet-genomics-in-raising-a-eur-4-5-million-venture-capital-investment\/#breadcrumb\"},\"inLanguage\":\"lt-LT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/triniti.eu\/lt\/patirtis\/triniti-jurex-represented-lithuanian-biotech-start-up-droplet-genomics-in-raising-a-eur-4-5-million-venture-capital-investment\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/triniti.eu\/lt\/patirtis\/triniti-jurex-represented-lithuanian-biotech-start-up-droplet-genomics-in-raising-a-eur-4-5-million-venture-capital-investment\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/triniti.eu\/lt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Triniti Jurex atstovavo lietuvi\u0173 biotechnologij\u0173 startuol\u012f \u201eDroplet Genomics\u201c pritraukiant 4,5 mln. Eur rizikos kapitalo investicij\u0105\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/triniti.eu\/#website\",\"url\":\"https:\/\/triniti.eu\/\",\"name\":\"TRINITI JUREX - Baltijos \u0161ali\u0173 advokat\u0173 kontora\",\"description\":\"The Future On Your Terms\",\"publisher\":{\"@id\":\"https:\/\/triniti.eu\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/triniti.eu\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"lt-LT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/triniti.eu\/#organization\",\"name\":\"Triniti\",\"url\":\"https:\/\/triniti.eu\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"lt-LT\",\"@id\":\"https:\/\/triniti.eu\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/triniti.eu\/wp-content\/uploads\/2021\/12\/triniti-logo-en.svg\",\"contentUrl\":\"https:\/\/triniti.eu\/wp-content\/uploads\/2021\/12\/triniti-logo-en.svg\",\"width\":400,\"height\":117,\"caption\":\"Triniti\"},\"image\":{\"@id\":\"https:\/\/triniti.eu\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Triniti Jurex atstovavo lietuvi\u0173 biotechnologij\u0173 startuol\u012f \u201eDroplet Genomics\u201c pritraukiant 4,5 mln. Eur rizikos kapitalo investicij\u0105 | TRINITI JUREX - Baltijos \u0161ali\u0173 advokat\u0173 kontora","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/triniti.eu\/lt\/patirtis\/triniti-jurex-represented-lithuanian-biotech-start-up-droplet-genomics-in-raising-a-eur-4-5-million-venture-capital-investment\/","og_locale":"lt_LT","og_type":"article","og_title":"Triniti Jurex atstovavo lietuvi\u0173 biotechnologij\u0173 startuol\u012f \u201eDroplet Genomics\u201c pritraukiant 4,5 mln. Eur rizikos kapitalo investicij\u0105 | TRINITI JUREX - Baltijos \u0161ali\u0173 advokat\u0173 kontora","og_description":"Lietuvi\u0173 biotechnologij\u0173 startuolis \u201eDroplet Genomics\u201c pritrauk\u0117 4,5 mln. Eur rizikos kapitalo investicij\u0105 bei paskelb\u0117, kad toliau bus \u017einomas nauju pavadinimu \u2013 \u201eAtrandi Biosciences\u201c. Pagrindiniai \u201elate seed\u201c stadijos raundo investuotojai buvo \u201eVsquared Ventures\u201c, pirmoji \u012fmon\u0117s investuotoja \u201ePractica Capital\u201c ir \u201eMeta Planet\u201c. Pritraukusi investicij\u0105 \u012fmon\u0117 ketina spartinti pl\u0117tr\u0105 \u012fsteigdama komand\u0105 JAV bei t\u0119sdama la\u0161eli\u0173 mikroskys\u010di\u0173 ir pavieni\u0173 [&hellip;]","og_url":"https:\/\/triniti.eu\/lt\/patirtis\/triniti-jurex-represented-lithuanian-biotech-start-up-droplet-genomics-in-raising-a-eur-4-5-million-venture-capital-investment\/","og_site_name":"TRINITI JUREX - Baltijos \u0161ali\u0173 advokat\u0173 kontora","article_modified_time":"2023-03-29T09:23:35+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minut\u0117"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/triniti.eu\/lt\/patirtis\/triniti-jurex-represented-lithuanian-biotech-start-up-droplet-genomics-in-raising-a-eur-4-5-million-venture-capital-investment\/","url":"https:\/\/triniti.eu\/lt\/patirtis\/triniti-jurex-represented-lithuanian-biotech-start-up-droplet-genomics-in-raising-a-eur-4-5-million-venture-capital-investment\/","name":"Triniti Jurex atstovavo lietuvi\u0173 biotechnologij\u0173 startuol\u012f \u201eDroplet Genomics\u201c pritraukiant 4,5 mln. Eur rizikos kapitalo investicij\u0105 | TRINITI JUREX - Baltijos \u0161ali\u0173 advokat\u0173 kontora","isPartOf":{"@id":"https:\/\/triniti.eu\/#website"},"datePublished":"2023-03-29T08:15:39+00:00","dateModified":"2023-03-29T09:23:35+00:00","breadcrumb":{"@id":"https:\/\/triniti.eu\/lt\/patirtis\/triniti-jurex-represented-lithuanian-biotech-start-up-droplet-genomics-in-raising-a-eur-4-5-million-venture-capital-investment\/#breadcrumb"},"inLanguage":"lt-LT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/triniti.eu\/lt\/patirtis\/triniti-jurex-represented-lithuanian-biotech-start-up-droplet-genomics-in-raising-a-eur-4-5-million-venture-capital-investment\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/triniti.eu\/lt\/patirtis\/triniti-jurex-represented-lithuanian-biotech-start-up-droplet-genomics-in-raising-a-eur-4-5-million-venture-capital-investment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/triniti.eu\/lt\/"},{"@type":"ListItem","position":2,"name":"Triniti Jurex atstovavo lietuvi\u0173 biotechnologij\u0173 startuol\u012f \u201eDroplet Genomics\u201c pritraukiant 4,5 mln. Eur rizikos kapitalo investicij\u0105"}]},{"@type":"WebSite","@id":"https:\/\/triniti.eu\/#website","url":"https:\/\/triniti.eu\/","name":"TRINITI JUREX - Baltijos \u0161ali\u0173 advokat\u0173 kontora","description":"The Future On Your Terms","publisher":{"@id":"https:\/\/triniti.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/triniti.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"lt-LT"},{"@type":"Organization","@id":"https:\/\/triniti.eu\/#organization","name":"Triniti","url":"https:\/\/triniti.eu\/","logo":{"@type":"ImageObject","inLanguage":"lt-LT","@id":"https:\/\/triniti.eu\/#\/schema\/logo\/image\/","url":"https:\/\/triniti.eu\/wp-content\/uploads\/2021\/12\/triniti-logo-en.svg","contentUrl":"https:\/\/triniti.eu\/wp-content\/uploads\/2021\/12\/triniti-logo-en.svg","width":400,"height":117,"caption":"Triniti"},"image":{"@id":"https:\/\/triniti.eu\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/triniti.eu\/lt\/wp-json\/wp\/v2\/experience\/23536","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/triniti.eu\/lt\/wp-json\/wp\/v2\/experience"}],"about":[{"href":"https:\/\/triniti.eu\/lt\/wp-json\/wp\/v2\/types\/experience"}],"acf:post":[{"embeddable":true,"href":"https:\/\/triniti.eu\/lt\/wp-json\/wp\/v2\/people\/3862"},{"embeddable":true,"href":"https:\/\/triniti.eu\/lt\/wp-json\/wp\/v2\/people\/3858"},{"embeddable":true,"href":"https:\/\/triniti.eu\/lt\/wp-json\/wp\/v2\/people\/9077"}],"wp:attachment":[{"href":"https:\/\/triniti.eu\/lt\/wp-json\/wp\/v2\/media?parent=23536"}],"wp:term":[{"taxonomy":"experience_practice_area","embeddable":true,"href":"https:\/\/triniti.eu\/lt\/wp-json\/wp\/v2\/experience_practice_area?post=23536"},{"taxonomy":"person_countries","embeddable":true,"href":"https:\/\/triniti.eu\/lt\/wp-json\/wp\/v2\/person_countries?post=23536"},{"taxonomy":"people_industries","embeddable":true,"href":"https:\/\/triniti.eu\/lt\/wp-json\/wp\/v2\/people_industries?post=23536"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}